Since 2007, Mary Ellen Perry, Ph.D., has been a program leader in the Office of Strategic Coordination, overseeing the development, implementation and assessment of several cutting edge programs. Prior to joining the Office of the Director, Dr. Perry was a program director for the National Cancer Institute, where she oversaw a grant portfolio focused on research in aspects of molecular biology of particular relevance to cancer. Dr. Perry also maintains a laboratory at the National Cancer Institute, employing genetically engineered mice to explore the relationship between development and cancer. Her background in cancer research is founded on a Ph.D. in biochemistry from the University of North Carolina and post-doctoral fellowships at Princeton University and the Imperial Cancer Research Fund, London (now part of Cancer Research, UK). For seven years, she led a cancer research laboratory at the University of Wisconsin-Madison, where she succeeded in winning two NIH grants, publishing several papers, and training five Ph.D. students, two of whom are now professors.